Table 3. Sites of mucormycosis in patients with COVID-19 by severity and outcome of illness, Pune, India.
| Site | COVID-19 severity, no. patients (%) |
Outcome, no. patients (%) |
|||||
|---|---|---|---|---|---|---|---|
| Mild, n = 29 | Moderate, n = 122 | Severe, n = 8 | Active, n = 5 | Discharged, n = 147 | Died, n = 26 | ||
| Unifocal, n = 71 | |||||||
| Localized sinus, n = 71 |
13 (45) |
51 (42) |
3 (37) |
|
2 (40) |
59 (40) |
10 (38) |
| Multifocal, n = 107 | |||||||
| Generalized, n = 52 | 5 (18) | 37 (30) | 3 (37) | 3 (60) | 38 (26) | 11 (42) | |
| Rhino-sinus, n = 6 | 3 (10) | 2 (2) | 1 (13) | 0 | 5 (3) | 1 (4) | |
| Rhino-orbital, n = 43 | 6 (21) | 30 (25) | 1 (13) | 0 | 41 (29) | 2 (8) | |
| Rhino-cerebral, n = 2 | 1 (3) | 0 | 0 | 0 | 2 (1) | 0 | |
| Rhino-orbito-cerebral, n = 4 | 1 (3) | 2 (2) | 0 | 0 | 2 (1) | 2 (8) | |